|
1
|
Bahrami A and Folpe AL: Adult-type
fibrosarcoma: a reevaluation of 163 putative cases diagnosed at a
single institution over a 48-year period. Am J Surg Pathol.
34:1504–1513. 2010.PubMed/NCBI
|
|
2
|
Fisher C: The value of electron microscopy
and immunohistochemistry in the diagnosis of soft tissue sarcomas:
a study of 200 cases. Histopathology. 16:441–454. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pritchard DJ, Soule EH, Taylor WF and
Ivins JC: Fibrosarcoma - a clinicopathologic and statistical study
of 199 tumors of the soft tissues of the extremities and trunk.
Cancer. 33:888–897. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pritchard DJ, Sim FH, Ivins JC, et al:
Fibrosarcoma of bone and soft tissues of the trunk and extremities.
Orthop Clin North Am. 8:869–881. 1977.PubMed/NCBI
|
|
5
|
Scott SM, Reiman HM, Pritchard DJ and
Ilstrup DM: Soft tissue fibrosarcoma. A clinicopathologic study of
132 cases. Cancer. 64:925–931. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wibmer C, Leithner A, Zielonke N, et al:
Increasing incidence rates of soft issue sarcomas? A
population-based epidemiologic study and literature review. Ann
Oncol. 21:1106–1111. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Al-Hajj M and Clarke MF: Self-renewal and
solid tumor stem cells. Oncogene. 23:7274–7282. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hermann PC, Bhaskar S, Cioffi M and
Heeschen C: Cancer stem cells in solid tumors. Semin Cancer Biol.
20:77–84. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bansal N and Banerjee D: Tumor initiating
cells. Curr Pharm Biotechnol. 10:192–196. 2009. View Article : Google Scholar
|
|
10
|
O’Brien CA, Kreso A and Dick JE: Cancer
stem cells in solid tumors: an overview. Semin Radiat Oncol.
19:71–77. 2009.
|
|
11
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
et al: Prospective identification of tumorigenic breast cancer
cells. Proc Natl Acad Sci USA. 100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Singh SK, Clarke ID, Terasaki M, et al:
Identification of a cancer stem cell in human brain tumors. Cancer
Res. 63:5821–5828. 2003.PubMed/NCBI
|
|
15
|
Collins AT, Berry PA, Hyde C, et al:
Prospective identification of tumorigenic prostate cancer stem
cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen SY, Huang YC, Liu SP, et al: An
overview of concepts for cancer stem cells. Cell Transplant.
20:113–120. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gibbs CP, Kukekov VG, Reith JD, et al:
Stem-like cells in bone sarcomas: implications for tumorigenesis.
Neoplasia. 7:967–976. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li C, Heidt DG, Dalerba P, et al:
Identification of pancreatic cancer stem cells. Cancer Res.
67:1030–1037. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ciavarella S, Milano A, Dammacco F and
Silvestris F: Targeted therapies in cancer. BioDrugs. 24:77–88.
2010. View Article : Google Scholar
|
|
20
|
Mizrak D, Brittan M and Alison M: CD133:
molecule of the moment. J Pathol. 214:3–9. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ceder JA, Jansson L, Ehrnström RA, et al:
The characterization of epithelial and stromal subsets of candidate
stem/progenitor cells in the human adult prostate. Eur Urol.
53:524–531. 2008. View Article : Google Scholar
|
|
22
|
Curley MD, Therrien VA, Cummings CL, et
al: CD133 expression defines a tumor initiating cell population in
primary human ovarian cancer. Stem Cells. 27:2875–2883.
2009.PubMed/NCBI
|
|
23
|
Rutella S, Bonanno G, Procoli A, et al:
Cells with characteristics of cancer stem/progenitor cells
expresses the CD133 antigen in human endometrial tumors. Clin
Cancer Res. 15:4299–4311. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Suvà ML, Riggi N, Stehle JC, et al:
Identification of cancer stem cells in Ewing’s sarcoma. Cancer Res.
69:1776–1781. 2009.
|
|
25
|
Tirino V, Desiderio V, d’Aquino R, et al:
Detection and characterization of CD133+ cancer stem
cells in human solid tumors. PLoS One. 3:e34692008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang J, Wang H, Li Z, et al: c-Myc is
required for maintenance of glioma cancer stem cells. PLoS One.
3:e37692008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hadnagy A, Gaboury L, Beaulieu R and
Balicki D: SP analysis may be used to identify cancer stem cell
populations. Exp Cell Res. 312:3701–3710. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Moserle L, Ghisi M, Amadori A and
Indraccolo S: Side population and cancer stem cells: therapeutic
implications. Cancer Lett. 288:1–9. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu C and Alman BA: Side population cells
in human cancers. Cancer Lett. 268:1–9. 2008. View Article : Google Scholar
|
|
30
|
Kelberman D, de Castro SC, Huang S, et al:
SOX2 plays a critical role in the pituitary, forebrain, and
eye during human embryonic development. J Clin Endocrinol Metab.
93:1865–1873. 2008. View Article : Google Scholar
|
|
31
|
Maruyama M, Ichisaka T, Nakagawa M and
Yamanaka S: Differential roles for Sox15 and Sox2 in
transcriptional control in mouse embryonic stem cells. J Biol Chem.
280:24371–24379. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Medvedev SP, Shevchenko AI, Mazurok NA and
Zakiian SM: OCT4 and NANOG are the key genes in the system of
pluripotency maintenance in mammalian cells. Genetika.
44:1589–1608. 2008.(In Russian).
|
|
33
|
Tokuzawa Y, Kaiho E, Maruyama M, et al:
Fbx15 is a novel target of Oct3/4 but is dispensable for embryonic
stem cell self-renewal and mouse development. Mol Cell Biol.
23:2699–2708. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Brunk BP, Martin EC and Adler PN:
Drosophila genes posterior sex combs and suppressor two of zeste
encodes proteins with homology to the murine bmi-1 oncogene.
Nature. 353:351–353. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Iwama A, Oguro H, Negishi M, et al:
Enhanced self-renewal of hematopoietic stem cells mediated by the
polycomb gene product Bmi-1. Immunity. 21:843–851. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lessard J and Sauvageau G: Bmi-1
determines the proliferative capacity of normal and leukaemic stem
cells. Nature. 423:255–260. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Choi CH: ABC transporters as multidrug
resistance mechanisms and the development of chemosensitizers for
their reversal. Cancer Cell Int. 5:302005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Vasiliou V, Vasiliou K and Nebert DW:
Human ATP-binding cassette (ABC) transporter family. Hum Genomics.
3:281–290. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jin Y, Bin ZQ, Qiang H, et al: ABCG2 is
related with the grade of glioma and resistance to mitoxantone, a
chemotherapeutic drug for glioma. J Cancer Res Clin Oncol.
135:1369–1376. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liang Y, Russell I, Walworth C and Chen C:
Gene expression in stem cells. Crit Rev Eukaryot Gene Expr.
19:289–300. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Pascal LE, Oudes AJ, Petersen TW, et al:
Molecular and cellular characterization of ABCG2 in the prostate.
BMC Urol. 7:62007. View Article : Google Scholar
|
|
42
|
Takara K, Sakaeda T and Okumura K: An
update on overcoming MDR1 mediated multidrug resistance in cancer
chemotherapy. Curr Pharm Des. 12:273–286. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Sharom FJ: ABC multidrug transporters:
structure, function and role in chemoresistance. Pharmacogenomics.
9:105–127. 2008. View Article : Google Scholar : PubMed/NCBI
|
